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INTRODUCTION
Cells are constantly exposed to genotoxic stress, and respond by activating dedicated DNA damage signaling and repair pathways that safeguard genome stability (Aguilera and García-Muse, 2013; Ciccia and Elledge, 2010; Hoeijmakers, 2009; Jackson and Bartek, 2009) . DNA damage signaling consists in the activation of checkpoint kinase cascades upon DNA damage detection/processing to coordinate cell cycle progression with DNA repair (Lazzaro et al., 2009; Shaltiel et al., 2015) . Adding another layer of complexity to these highly orchestrated cellular responses, damage signaling and repair machineries operate on chromatin substrates in eukaryotic cell nuclei, where DNA wraps around histone proteins (Luger et al., 2012) . Importantly, chromatin landscapes, defined by specific patterns of histone variants (Buschbeck and Hake, 2017; Talbert and Henikoff, 2017) , post-translational modifications (Bannister and Kouzarides, 2011) and various degrees of chromatin folding, convey epigenetic information that instructs cell function and identity through the regulation of gene expression programs (Allis and Jenuwein, 2016) . While the importance of maintaining epigenome integrity is widely recognized, it is still poorly understood how this is achieved during the DNA damage response.
DNA damage signaling and repair indeed elicit profound chromatin rearrangements, challenging epigenome maintenance , with a transient destabilization of chromatin organization, accompanied by DNA damage-induced changes in histone modifications (Dantuma and van Attikum, 2016) . Chromatin structure is then restored concomitantly with the repair of DNA damage (Polo and Almouzni, 2015; Smerdon, 1991) . It remains unclear whether chromatin restoration after damage is an entirely faithful process or if genotoxic stress responses alter the epigenetic landscape, leaving a signature of DNA damage repair. Although not fully characterized yet, restoration of chromatin at damage sites involves the deposition of newly synthesized histones, as shown at sites of UVA and UVC ! 4! damage in human cells with the de novo deposition of H2A, H3.1 and H3.3 histone variants (Adam et al., 2013; Dinant et al., 2013; Luijsterburg et al., 2016; Polo et al., 2006) .
Mechanistically, new histone deposition employs dedicated histone chaperones (Hammond et al., 2017) , including the H3 variant-specific chaperones HIRA (Histone Regulator A) and CAF-1 (Chromatin Assembly Factor-1), which are recruited to UV-damaged chromatin by early and late repair proteins, respectively (Adam et al., 2013; Polo et al., 2006) . Less is known about the factors that govern H2A dynamics in damaged chromatin, apart from a role for the histone chaperone FACT in promoting H2A-H2B turnover at UVC damage sites (Dinant et al., 2013) . Regarding the histone variant H2A.Z, its dynamic exchange at sites of DNA double-strand breaks in human cells involves the concerted action of the histone chaperone ANP32E and of the chromatin remodeling factors p400 and INO80 (Inositolrequiring 80) (Alatwi and Downs, 2015; Gursoy-Yuzugullu et al., 2015; Xu et al., 2012) .
Here, we investigate how such repair-coupled chromatin rearrangements may leave an imprint on the epigenetic landscape and cross-talk with damage signaling by focusing on the H2A.X histone variant, which represents the ancestral form of H2A, conserved in all eukaryotes (Talbert and Henikoff, 2010) . Making up only 10 to 25% of total H2A, H2A.X is nevertheless central to the DNA damage response, owing to a particular carboxyl-terminal Serine, in position 139 in mammals, that is targeted by DNA damage responsive kinases (Bonner et al., 2008; Rogakou et al., 1998) . Importantly, H2A.X S139 phosphorylation spreads at a distance from the damage (Rogakou et al., 1999) , which is key for amplifying the DNA damage signal through the coordinated recruitment of DNA damage checkpoint mediators (Altmeyer and Lukas, 2013; Smeenk and van Attikum, 2013) . Best described in response to DNA doublestrand breaks, this signaling cascade also operates following other types of genomic insults including UV irradiation. Indeed, UV damage processing triggers checkpoint signaling (Marini et al., 2006) by activating the ATR (ataxia telangiectasia-mutated and Rad3-related) ! 5! kinase, which phosphorylates H2A.X (Hanasoge and Ljungman, 2007) . This in turns recruits checkpoint mediators, including MDC1 (Mediator of DNA damage Checkpoint 1) (Marteijn et al., 2009) .
Regardless of which type of DNA insult activates the H2A.X signaling cascade, a salient feature of H2A.X phosphorylation is that it takes place in situ in damaged chromatin (Rogakou et al., 1998) . The original distribution of H2A.X in chromatin is thus a critical determinant of the damage response, as it will govern the distribution of the phosphorylated form, known as γH2A.X. A commonly held view is that H2A.X is phosphorylated at DNA damage sites but ubiquitously incorporated in chromatin, independently of DNA damage.
However, recent ChIP-seq studies in mammalian cells have challenged this view by revealing a non-random distribution of H2A.X, with enrichments at active transcription start sites and sub-telomeric regions in activated human lymphocytes (Seo et al., 2014; , and at extraembryonic genes in mouse pluripotent stem cells (Wu et al., 2014) . Yet, the mechanisms underpinning the non-random distribution of H2A.X in chromatin are unknown, as is their potential connection to the DNA damage response.
In this study, by investigating the mechanisms governing H2A.X distribution in chromatin during the repair of UVC damage in mammalian cells, we reveal that H2A.X histones are deposited de novo in damaged chromatin by the histone chaperone FACT concomitantly with repair synthesis. We also uncover a H2A.Z/H2A.X exchange reaction orchestrated by FACT and ANP32E chaperones, which reshapes the chromatin landscape by altering the histone variant pattern at UV damage sites. Functionally, these histone chaperones are key for mounting an efficient cellular response to DNA damage, with FACT potentiating H2A.Xdependent damage signaling.
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RESULTS
De novo deposition of H2A histone variants at repair sites
In order to characterize H2A.X deposition pathways, we monitored de novo histone deposition using the SNAP-tag technology (Bodor et al., 2012) in human U2OS cell lines stably expressing SNAP-tagged H2A variants ( Figure 1A and Figure S1 for a characterization of the cell lines). Specific labeling of newly synthesized histones combined with local UVC irradiation did not reveal any detectable accumulation of new H2A variants at UVC damage sites, contrary to what we had observed with newly synthesized H3.3 (Adam et al., 2013) ( Figure 1B ). We reasoned that this discrepancy might be due to differences in mobility between inner core histones, H3-H4, and outer core histones, H2A-H2B, the latter being more readily exchanged (Kimura and Cook, 2001; Louters and Chalkley, 1985) , which may hinder the detection of local histone accumulations. Since outer core histone mobility is partly transcription-dependent (Jackson, 1990; Kimura and Cook, 2001) , we tracked new histones in the presence of transcription inhibitors, Flavopiridol, DRB or α-amanitin (Bensaude, 2011) ( Figures 1C and S2A ). Note that short-term transcription inhibition reduces but does not abolish histone neosynthesis because of pre-existing mRNAs. Thus, we revealed new H2A.X accumulation at sites of UVC damage in the vast majority of cells (over 85%, Figure 1C -E), and we recapitulated our observations in mouse embryonic fibroblasts ( Figure S3A -D).
Importantly, new H2A.X accumulation at UVC damage sites was not an artifact of transcription inhibition as it was also detectable in the absence of transcription inhibitors upon exposure to higher UVC doses ( Figure S2B ). In contrast to new H2A.X, no significant enrichment was observed at damaged sites when staining for total H2A.X ( Figure 1D ), showing that this accumulation was specific for newly synthesized histones and most likely reflects histone exchange at damage sites. Noteworthy, de novo accumulation of H2A.X was ! 7! also observed at sites of UVA laser micro-irradiation ( Figure S2C ), arguing that it is not unique to the UVC damage response.
In order to assess whether new H2A.X deposition at UVC damage sites was specific for the damage-responsive histone H2A.X, we extended our analyses to other H2A variants, namely canonical H2A and another replacement variant conserved in all eukaryotes, H2A.Z, considering both H2A.Z.1 and H2A.Z.2 forms, which display different dynamics in response to UVA laser damage in human cells (Nishibuchi et al., 2014) . For this, we established U2OS cell lines that stably express comparable levels of SNAP-tagged H2A variants ( Figure S1 ).
Similar to what observed for H2A.X, we detected de novo accumulation of the canonical replicative variant H2A, but not of the replacement variants H2A.Z.1 and H2A.Z.2, at UVC damage sites ( Figure 1E ). Similar results were obtained without transcription inhibition ( Figure S2D ), pointing to a specific histone deposition mechanism that is not general to all H2A variants.
Collectively, these data reveal a transcription-independent deposition of newly synthesized H2A and H2A.X but not H2A.Z histone variants at repair sites.
New H2A.X deposition at repair sites is independent of S139 phosphorylation
We next examined the importance of H2A.X S139 phosphorylation status for new H2A.X deposition at repair sites. We first verified that the SNAP-tag in C-terminal did not prevent H2A.X phosphorylation (data not shown) and we compared the dynamics of H2A.X wildtype to phospho-mimetic (S139E) and phospho-deficient (S139A) mutants. These experiments consistently showed that new H2A.X accumulation at sites of UVC damage repair occurred irrespective of H2A.X S139 phosphorylation status ( Figure 1E ). Since SNAPtagged H2A.X proteins are expressed in the context of wild-type endogenous H2A.X, we used a complementary approach to address the importance of H2A.X phosphorylation: we treated ! 8! cells with an ATR kinase inhibitor, which inhibited UV-induced H2A.X phosphorylation as reported (Hanasoge and Ljungman, 2007) , but did not impair the de novo deposition of H2A.X at UVC-damage sites ( Figure S4A ). Thus, H2A.X phosphorylation in response to DNA damage is dispensable for the deposition of new H2A.X at sites of DNA damage repair.
De novo deposition of H2A histone variants at replication foci
In parallel to our analysis of H2A.X dynamics at sites of DNA repair, we also monitored new H2A.X deposition in the absence of DNA damage. Indeed, we noticed that new H2A.X displayed a punctuate pattern in a subset of undamaged cells upon transcription inhibition.
This deposition pattern corresponded to replication foci, as shown by co-staining with the replication-coupled histone chaperone CAF-1 ( Figure 2A ). We observed new H2A.X accumulation at replication foci throughout S phase in human U2OS cells treated with transcription inhibitors ( Figure 2B ). In mouse embryonic fibroblasts, transcription inhibitors could be omitted to visualize new H2A.X accumulation in replicating heterochromatin domains, which are poorly transcribed by nature ( Figure S3E -F). Similar to H2A.X accumulation at repair sites, the enrichment observed at replication foci was specific for newly synthesized H2A.X ( Figure 2C ) and only detected for H2A and H2A.X, but not H2A.Z variants ( Figure 2D ).
Altogether, these findings demonstrate that newly synthesized H2A and H2A.X are deposited both at repair sites and at replication foci.
New H2A.X deposition is coupled to replicative and repair synthesis
To gain insights into the mechanisms underlying new H2A.X deposition at repair sites and replication foci, we investigated a possible dependency on DNA synthesis, which is a common feature of replication and UV damage repair. We prevented repair synthesis by ! 9! down-regulating the late repair factor XPG (Xeroderma Pigmentosum, group G), an endonuclease involved in the excision of the UVC-damaged oligonucleotide, which is a prerequisite for repair synthesis ( Figure 3A ). XPG knock-down did not impede damage detection by early repair factors including XPA but markedly reduced the accumulation of newly synthesized H2A.X at sites of UVC damage ( Figure 3B ) with no detectable effect on new H2A.X deposition at replication foci (data not shown). We confirmed that new H2A.X deposition at repair sites was dependent on the DNA synthesis machinery by knocking-down the DNA polymerase processivity factor PCNA (Proliferating Cell Nuclear Antigen, Figure   3C ). In line with these observations at repair sites, we also uncovered a dependency on DNA synthesis for new H2A.X deposition occurring at replication foci. Indeed, when we inhibited replicative synthesis with aphidicolin, the focal patterns of new H2A.X deposition were strongly reduced in S phase cells, identified by EdU (Ethynyl-deoxyUridine) labeling ( Figure   3D ). These results indicate that the deposition of newly synthesized H2A.X at replication foci and UVC damage sites is dependent on replicative and repair synthesis machineries.
New H2A.X deposition is not coupled to new H3 deposition
We next investigated whether new H2A.X deposition was coordinated with the deposition of newly synthesized H3 variants that occurs at replication and repair sites (Adam et al., 2013; Polo et al., 2006; Ray-Gallet et al., 2011) . Knocking down the histone chaperone CAF-1, responsible for new H3.1 deposition at UV sites (Polo et al., 2006) , did not significantly affect new H2A.X accumulation at sites of UVC damage repair ( Figure S4B ). Similar results were obtained upon down-regulation of the histone chaperone HIRA, which deposits new H3.3 at UV sites (Adam et al., 2013 ) ( Figure S4B ) and upon loss-of-function of both pathways simultaneously (data not shown). These data demonstrate that new H2A.X deposition occurs independently of new H3 deposition by CAF-1 and HIRA at UVC damage sites. ! 10!
The histone chaperone FACT promotes new H2A.X deposition at UV damage sites
To uncover the molecular determinants of new H2A.X accumulation at sites of UVC damage repair, we examined the effect of knocking down candidate H2A histone chaperones (Gurard-Levin et al., 2014; Hammond et al., 2017) and chromatin remodelers (Zhou et al., 2016) . We focused on the histone chaperone FACT (Belotserkovskaya et al., 2003) and on the chromatin remodeler INO80 (Shen et al., 2000) . Indeed, the latter is known to maintain the levels of chromatin-bound H2A.X in human cells (Seo et al., 2014) and to promote H2A deposition in yeast (Papamichos-Chronakis et al., 2006) , while FACT incorporates H2A and H2A.X but not H2A.Z into chromatin (Heo et al., 2008) and stimulates H2A turnover at UVC damage sites in human cells (Dinant et al., 2013) . Moreover, FACT associates with replisome components in human cells (Alabert et al., 2014; Tan et al., 2006) , is involved in replication-coupled nucleosome assembly in yeast (Yang et al., 2016) , and is critical for replisome progression through chromatin in vitro (Kurat et al., 2017) . Interestingly, we observed that FACT accumulation at sites of DNA replication and UV damage repair exhibited dependencies to replicative synthesis and to late repair steps similar to new H2A.X deposition, FACT accumulation being impaired at repair sites by XPG and PCNA knock-downs and at replication foci upon aphidicolin treatment (Figures 4A-C and S5A). Furthermore, FACT trapping to chromatin by the intercalating agent curaxin CBL0137 (Gasparian et al., 2011; Safina et al., 2017 ) ( Figure S5B ) impaired FACT accumulation and new H2A.X deposition at UVC damage sites ( Figure S5C -D). In line with these findings, siRNA-mediated downregulation of both FACT subunits, but not of the remodeler INO80, led to a marked reduction of newly deposited H2A.X at UVC damage sites ( Figure 4D ). The decrease in new H2A.X deposition was also observed in the whole nucleus, most likely reflecting replication-and transcription-coupled deposition of H2A.X by FACT, and cannot be explained by reduced ! 11! histone neo-synthesis as we verified that FACT knock-down does not inhibit nascent transcription ( Figure S6A ). De novo accumulation of H2A was similarly reduced in FACTknocked-down cells ( Figure S6B ). These results establish that new H2A and H2A.X deposition at repair sites is promoted by the histone chaperone FACT.
H2A.Z/H2A.X exchange in UVC-damaged chromatin
The de novo deposition of H2A and H2A.X but not H2A.Z that we observed at sites of UV damage repair ( Figure 1E ) parallels the reported specificity of FACT towards the variants of H2A (Heo et al., 2008) . We thus decided to examine whether this selective histone variant deposition by FACT may result in an altered histone variant pattern in UVC-damaged chromatin. Supporting this idea, when we stained for total histones, we observed that while H2A.X total levels were not detectably altered at sites of UVC irradiation (as also seen in Figure 1D ), H2A.Z total levels were reduced by about 10% in damaged chromatin ( Figure   5A previously characterized for its ability to remove H2A.Z from chromatin (Mao et al., 2014; Obri et al., 2014) . Notably, ANP32E-mediated removal of H2A.Z was dispensable for FACT recruitment and new H2A.X deposition at UVC damage sites ( Figure S7D -E). Thus, ANP32E and FACT chaperones independently orchestrate a histone variant exchange reaction in UVCdamaged chromatin resulting in the maintenance of H2A.X and the loss of H2A.Z.
FACT potentiates H2A.X-dependent signaling of DNA damage
Having identified FACT and ANP32E as key factors for H2A.Z/H2A.X exchange in damaged chromatin, we set out to determine the functional relevance of this mechanism. First, we observed that both FACT and ANP32E knock-downs confer increased sensitivity of cells to UVC damage ( Figure 6A ), suggesting that the histone variant exchange orchestrated by these two chaperones may be functionally important for the cells to mount an efficient DNA damage response. We further tested whether down-regulation of FACT or ANP32E might affect UVC damage repair. We observed that FACT and ANP32E knock-downs did not impair the recruitment of the repair factor XPA (Xeroderma Pigmentosum, group A) to UVC damage sites ( Figures 4D, 5A -B, S6B, and S7A,C,E). In addition, we found no significant effect of FACT loss-of-function on repair synthesis ( Figure S8A ), in line with previous data (Dinant et al., 2013) , and on the timely removal of UV photoproducts (Cyclobutane Pyrimidine Dimers, Figure S8B ), ruling out any major effect of this histone chaperone on UVC damage repair. Similarly, preventing new H2A.X synthesis by siRNA ( Figure S8C ) did not detectably impair UVC damage repair synthesis ( Figure S8D ), arguing that FACTmediated deposition of H2A.X in damaged chromatin does not impact DNA damage repair.
Likewise, ANP32E was dispensable for repair synthesis at sites of UVC damage ( Figure   S8E ). Together, these data do not reveal any significant contribution of FACT and ANP32E chaperones to the repair of UVC damage.
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We next investigated a potential impact of these chaperones on DNA damage signaling after UVC irradiation. In particular, we hypothesized that FACT-mediated deposition of new H2A.X could potentiate damage signaling by bringing in more phosphorylation targets for DNA damage-responsive kinases or contribute to turn off damage signaling at the end of repair by replacing γH2A.X by unphosphorylated H2A.X and H2A. To avoid misinterpretation of the data due to the interference of FACT knock-down with DNA replication, we restricted our analysis to non-replicating cells based on staining with EdU (Ethynyl-deoxyUridine). Thus, we noticed that γH2A.X levels were reduced by 30 to 35% at sites of UVC damage repair in FACT-depleted cells ( Figure 6B ), while H2A.X total levels did not show any measurable decrease as assessed in total cell extracts and also at damage sites ( Figure 6B and data not shown). Moreover, this reduction in γH2A.X levels did not result from lower damage infliction or from a diminished repair response because repair synthesis and repair factor recruitment were not significantly affected in the same cells (data not shown). In contrast to FACT loss-of-function, ANP32E depletion had no inhibitory effect on γH2A.X levels at UVC damage sites ( Figure 6B ). We also analyzed the recruitment to UVCdamaged chromatin of downstream damage signaling factors including the checkpoint mediator MDC1. In line with the reduced levels of γH2A.X, MDC1 accumulation at UVC damage sites also showed 30 to 40% reduction in FACT knocked-down cells while MDC1 total levels remained unaffected ( Figure 6B -C). Collectively, these results establish that FACT and ANP32E histone chaperones are critical for the cells to mount an efficient DNA damage response with FACT stimulating H2A.X-dependent signaling of DNA damage. ! 14!
DISCUSSION
By analyzing the dynamics of H2A histone variants in damaged chromatin, we have uncovered a H2A.Z/H2A.X exchange reaction controlled by two histone chaperones, ANP32E and FACT ( Figure 6D ). Chromatin restoration after UVC damage repair thus entails reshaping of the chromatin landscape through a change in histone variant pattern. We also reveal that H2A.X is deposited de novo at sites of DNA damage repair, a process which should be integrated in the DNA damage response, in addition to the well-characterized phosphorylation of H2A.X. We propose that repair-coupled deposition of new H2A.X constitutes an important additional regulation level for fine-tuning the DNA damage response.
By ensuring that the phosphorylation target for DNA damage checkpoint kinases is present in sufficient amount and at the right place, new H2A.X deposition may allow an efficient and timely response to genotoxic insults in chromatin regions that are susceptible to DNA damage.
New H2A.X deposition at sites of DNA synthesis during replication and repair
In our study, we uncover a selective deposition of newly synthesized H2A variants at sites of UVC damage repair, with H2A and H2A.X being deposited de novo in damaged chromatin while H2A.Z is not. This parallels our previous findings on H3 variants showing that H3.1 and H3.3 are deposited de novo in UVC-damaged chromatin in contrast to CENP-A (Adam et al., 2013; Polo et al., 2006) . Nevertheless, we demonstrate that new H2A.X deposition is not coupled with new H3.1/H3.3 deposition at repair sites. These results are in line with pioneering observations that newly synthesized H2A and H3 do not deposit within the same nucleosomes in replicating cells (Jackson, 1987) , and suggest that new H2A.X-H2B associate with parental H3-H4 in repaired chromatin. We have also observed a selective deposition of H2A.X and H2A but not H2A.Z variants on replicating DNA, which is consistent with a ! 15! recent study in mouse pericentric heterochromatin domains showing a replication-dependent deposition of new H2A and not H2A.Z (Boyarchuk et al., 2014) , and with recent proteomic analyses of histone variants associated with newly replicating DNA in human cells (Alabert et al., 2015) . The coupling between new H2A.X deposition and DNA replication is intriguing considering that H2A.X is not a prototypical replicative histone variant. Indeed, H2A.X is synthesized at basal levels throughout the cell cycle in mammalian cells, in a replicationindependent manner (Wu and Bonner, 1981) . Nevertheless, the lack of introns and the existence of a non-polyadenylated form of H2A.X mRNA -both characterizing replicative histone transcripts -place H2A.X in a unique position between replicative and replacement histone variants (Mannironi et al., 1989) . Functionally, the deposition of newly synthesized H2A.X at replication foci may ensure that H2A.X is not diluted out during replication, which would happen if only the bona fide replicative variant H2A was deposited. Such replicationcoupled deposition of H2A.X could also explain the increase in soluble H2A.X detected in human cells treated with replication inhibitors (Liu et al., 2008) . Furthermore, the de novo deposition of H2A.X that we have uncovered at repair sites may provide a molecular basis for the H2A.X hotspots found in chromatin regions that are susceptible to endogenous damage (Seo et al., 2014) . We can speculate that the observed enrichment of H2A.X may be a consequence of recurrent genomic insults. H2A.X could thus mark chromatin regions that are more susceptible to damage to facilitate subsequent damage responses. Noteworthy, the H2A.X protein was also shown to be rapidly stabilized following DNA damage, contributing to a local enrichment at repair sites (Atsumi et al., 2015) . However, this stabilization required H2A.X phosphorylation on Ser139, while we found that new H2A.X deposition at repair sites occured independently of H2A.X phosphorylation. H2A.X protein stabilization and de novo deposition thus appear to be two distinct and complementary mechanisms contributing to the distribution of H2A.X in chromatin, which reflects DNA damage experience.
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Role of the histone chaperone FACT in new H2A.X deposition
We have identified FACT as the responsible histone chaperone for new H2A and H2A.X deposition at repair sites. Interestingly, FACT also promotes the deposition of another H2A variant, macroH2A1.2, at sites of replication stress in mammalian cells (Kim et al., 2017) .
However, FACT does not incorporate H2A.Z in chromatin (Heo et al., 2008) , which is consistent with the lack of new H2A.Z deposition at sites of DNA synthesis. We demonstrate that FACT-mediated deposition of new H2A.X at damage sites is concomitant with repair synthesis and dependent on the DNA polymerase sliding clamp PCNA. This is reminiscent of the recruitment of CAF-1 to damaged DNA (Moggs et al., 2000) , putting forward PCNA as a platform for histone chaperone recruitment to damaged chromatin. It will be interesting to examine whether FACT directly associates with PCNA. This is an attractive hypothesis considering that the FACT subunit SSRP1 (Structure-Specific Recognition Protein 1) harbors a non-canonical PIP (PCNA interacting protein) box (Mailand et al., 2013) . Alternatively, FACT interaction with PCNA could be mediated by PCNA-binding factors like XRCC1 (Xray repair cross-complementing protein 1) , which contributes to UVC damage repair (Moser et al., 2007) , and was recently reported to associate with the FACT complex subunit SSRP1 (Gao et al., 2017) . In addition, other factors associated with the DNA synthesis machinery and shown to cooperate with FACT, like MCM (MiniChromosome Maintenance) proteins (Tan et al., 2006) , could also contribute to FACT recruitment to sites of UV damage repair.
Impact of new H2A.X deposition on DNA damage signaling and repair
Although H2A.X is deposited de novo at sites of UVC damage repair, we have observed that this histone variant is not required for the repair of UVC lesions. In this respect, our findings ! 17! are in line with previous studies in mouse embryonic stem cells knocked-out for H2A.X, which display increased genomic instability but are not particularly sensitive to UV irradiation (Bassing et al., 2002) . Similar to H2A.X, the histone chaperone FACT is dispensable for repair synthesis at UV damage sites. This contrasts with FACT requirement for replicative DNA synthesis (Abe et al., 2011; Kurat et al., 2017; Okuhara et al., 1999) , suggesting that FACT-mediated chromatin disassembly/re-assembly activity is more critical for replication fork progression through chromatin than for DNA synthesis per se.
Besides an effect on DNA repair, we also tested whether FACT-mediated deposition of new H2A.X in damaged chromatin may help coordinate DNA repair synthesis with damage signaling. Interestingly, the histone chaperones ASF1 and CAF-1 are required for checkpoint termination in response to DNA double-strand breaks (Chen et al., 2008; Diao et al., 2017; Kim and Haber, 2009 ), suggesting that the re-establishment of nucleosomal arrays contributes to turning off DNA damage signaling after repair of DNA damage. FACT in contrast enhances γH2A.X levels at sites of UV damage repair, thus potentiating DNA damage signaling. Although we cannot rule our that other FACT-dependent activities may be involved, it is tempting to speculate that FACT stimulates damage signaling through new H2A.X deposition. While this does not lead to any measurable increase in H2A.X total levels at repair sites, it may be enough to help amplify the γH2A.X signal. The repair-coupled deposition of H2A.X may also be functionally important for efficient signaling during a subsequent damage response by maintaining critical levels of H2A.X in chromatin regions susceptible to DNA damage.
H2A.Z/H2A.X exchange at sites of DNA damage repair
Not only have we shown that H2A.X is deposited de novo at sites of UV damage repair but we have also observed that this is paralleled by the removal of H2A.Z, resulting in a local ! 18! change in histone variant pattern. It still remains to be determined if the histone variant exchange takes place at the level of the nucleosome, H2A.X replacing H2A.Z, or at the level of the damaged chromatin domain. H2A.Z is removed from UVC-damaged chromatin by the histone chaperone ANP32E, showing interesting similarities with what has been reported in response to UVA laser damage (Gursoy-Yuzugullu et al., 2015) . However, in this case ANP32E activity results in H2A.Z returning to basal levels in damaged chromatin after a transient accumulation while we observe a local loss of H2A.Z at UVC damage sites. We did not find any significant role for the remodeler INO80 in H2A.Z removal from UVC-damaged chromatin, in contrast to what observed at sites of UVA laser damage in human cells (Alatwi and Downs, 2015) , suggesting that different types of DNA lesions may engage different chromatin remodeling machineries.
We have shown that ANP32E increases cell survival to UVC irradiation, suggesting that ANP32E-mediated removal of H2A.Z from UVC-damaged chromatin may be of functional importance. Given that H2A.Z promotes chromatin folding in vitro (Fan et al., 2002; , the local depletion of H2A.Z could contribute to the chromatin relaxation observed at UVC damage sites (Adam et al., 2016; Luijsterburg et al., 2012) . In line with this hypothesis, H2A.Z removal by ANP32E is required for histone H4 acetylation at sites of DNA doublestrand breaks (Gursoy-Yuzugullu et al., 2015) . Future studies will help decipher the functional contribution to the UV damage response of H2A.Z displacement by ANP32E and dissect potential crosstalks with other pathways controlling histone variant dynamics in damaged chromatin.
Dynamics of H2A variants at repair sites and transcription regulation
While we have shown that the de novo deposition of H2A and H2A.X at repair sites was not transcription-mediated, it could impact transcription regulation in damaged chromatin. In ! 19! particular, given the reported function of FACT in regulating transcription recovery after UVC damage in human cells (Dinant et al., 2013) , FACT-mediated deposition of new H2A variants in UVC-damaged chromatin could facilitate the coordination of repair synthesis with transcription restart. Tipping the balance towards H2A and H2A.X as opposed to H2A.Z could also help keeping transcription in check and avoiding transcription interference with repair because H2A.Z was proposed to poise genes for transcription activation (Zhang et al., 2005) and to promote unscheduled/cryptic transcription when mislocalized in yeast cells (Jeronimo et al., 2015) . It is thus tempting to speculate that H2A.Z/H2A.X histone variant exchange at UV sites may contribute to mitigate transcription-repair conflicts by maintaining transcription inhibition during repair synthesis. In this respect, it is worth mentioning that FACT was shown to limit the formation of RNA:DNA hybrids in yeast and human cells (Herrera-Moyano et al., 2014) . It would thus be of major interest to investigate whether this function of FACT relies on the de novo deposition of H2A histone variants on newly synthesized DNA.
New H2A.X deposition in damaged chromatin could also have a broader impact on transcription regulation. Indeed, several recent studies have uncovered a critical role for H2A.X in regulating gene expression patterns during cell differentiation. In particular, H2A.X is involved in silencing of extra-embryonic genes in mouse embryonic stem cells (Wu et al., 2014) , and also represses genes governing the epithelial-mesenchymal transition in human cells (Weyemi et al., 2016) . Therefore, alterations in H2A.X distribution as a consequence of DNA damage experience may impact cell fate determination via the rewiring of transcriptional programs, thus contributing to the reported effect of DNA damage repair on cell differentiation and reprogramming (Rocha et al., 2013) . ! 20!
METHOD DETAILS
Cell culture and drug treatments
All U2OS (American Type Culture Collection ATCC HTB-96, human osteosarcoma, female) and NIH/3T3 (ATCC CRL-1658, mouse embryonic fibroblast, male) cell lines were grown at 37°C and 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM, Invitrogen) supplemented with 10% fetal calf serum (EUROBIO), 100 U/mL penicillin and 100 µg/mL streptomycin (Invitrogen) and the appropriate selection antibiotics (Table 1) Cell line (reference if not generated in this study) Selection antibiotics U2OS H2A.X-SNAP WT form G418 U2OS H2A.X-SNAP S139A mutant G418 U2OS H2A.X-SNAP S139E mutant G418 U2OS H2A.Z.1-SNAP G418 U2OS H2A.Z.2-SNAP G418 U2OS H2A-SNAP G418 U2OS H3.3-SNAP (Dunleavy et al., 2011) G418 NIH/3T3 H2A.X-SNAP + GFP-DDB2 G418 + Hygromycin 
SNAP-tag labeling of histone proteins
For specific labeling of newly-synthesized histones, pre-existing SNAP-tagged histones were ! 21! first quenched by incubating cells with 10 µM non-fluorescent SNAP reagent (SNAP-Cell Block, New England Biolabs) for 30 min (quench) followed by a 30 min-wash in fresh medium and a 2 h-chase. The SNAP-tagged histones neo-synthesized during the chase were then pulse-labeled by incubation with 2 µM red-fluorescent SNAP reagent (SNAP-Cell TMR-Star, New England Biolabs) for 15 min followed by 1h to 1h30-wash in fresh medium. Cells were pre-extracted with Triton detergent before fixation (see Immunofluorescence section for details). If cells were subject to local UVC irradiation, irradiation was performed immediately before the pulse. When transcription inhibitors were used, they were added to the medium at the quench step and kept throughout the experiment. For total labeling of SNAP-tagged histones, the quench step was omitted and cells were pulsed with SNAP-Cell TMR-Star immediately before harvesting.
Designation
Target sequence siANP32E#1 5' AUGGAUUUGAUCAGGAGGAUA 3' siANP32E#2 5' UUGGAGCUUAGUGAUAAUAUA 3' siFACT#1 1:1 combination of siSPT16: 5' GGAAUUAAGACAUGGUGUG 3' and siSSRP1: 5' GAUGAGAUCUCCUUUGUCA 3' siFACT#2 1:1 combination of siSPT16: 5' ACAUCAGCAUAUGCAUGAC 3' and siSSRP1: 5' UGAGGUGACACUGGAAUUC 3' siFACT#3 1:1 combination of siSPT16: 5' ACCGGAGUAAUCCGAAACUGA 3' and siSSRP1: 5' UUCGUUGACUCUGAACAUGAA 3' siH2A.X 5' CAACAAGAAGACGCGAAUC 3' siHIRA 5' GGAGAUGACAAACUGAUUA 3' siINO80#1 5' GGAGUUAUUUGAACGGCAA 3' siINO80#2 5' ACUUGGUCUCCAUUUCAUA 3' siLUC (Luciferase) 5' CGUACGCGGAAUACUUCGA 3' siCAF-1 p60 5' AAUCUUGCUCGUCAUACCAAA 3' siPCNA#1 5' CCGAGAUCUCAGCCAUAUU 3' siPCNA#2 5' GGAGGAAGCUGUUACCAUA 3' siXPG#1 5' GAAAGAAGAUGCUAAACGU 3' siXPG#2 5' GGAGAAAGAAUUUGAGCUA 3' according to manufacturer's instructions 48 h before antibiotic selection of clones. All constructs were verified by direct sequencing and/or restriction digests. Cloning details and primer sequences (Sigma-Aldrich) are available upon request. Plasmids are described in Table   3 .
Plasmid
Construct details H2A.X-SNAP (WT)
H2AFX coding sequence cloned into pSNAPm (New England Biolabs)
H2A.X-SNAP (S139A)
H2AFX coding sequence with insertion of a silent mutation S139A (TCC to GCG) cloned into pSNAPm (New England Biolabs) H2A.X-SNAP (S139E) H2AFX coding sequence with insertion of a mutation S139E (TCC to GAG) cloned into pSNAPm (New England Biolabs) H2A.Z.1-SNAP H2AFZ coding sequence cloned into pSNAPm (New England Biolabs) H2A.Z.2-SNAP H2AFV coding sequence cloned into pSNAPm (New England Biolabs) H2A-SNAP HIST1H2AM coding sequence cloned into pSNAPm (New England Biolabs) H3.3-SNAP H3F3B coding sequence cloned into pSNAPm (New England Biolabs) (Dunleavy et al., 2011) 
GFP-DDB2
DDB2 coding sequence (Montpellier Genomic Collections) subcloned into GFP-XPC plasmid (Nishi et al., 2009) replacing XPC (Adam et al., 2016) 
UVC irradiation
Cells grown on glass coverslips (Menzel Gläser) were irradiated with UVC (254 nm) using a low-pressure mercury lamp. Conditions were set using a VLX-3W dosimeter (Vilbert-Lourmat). For global UVC irradiation, cells in Phosphate Buffer Saline (PBS) were exposed to UVC doses ranging from 4 to 12 J/m 2 by varying the duration of exposure. For local UVC irradiation (Katsumi et al., 2001; Moné et al., 2001) , cells were covered with a polycarbonate filter (5 µm pore size, Millipore) and irradiated with 150 J/m 2 UVC unless indicated otherwise. Only 2% of the UVC light goes through these micropore filters.
! 23!
UVA laser micro-irradiation
Cells grown on glass coverslips (Menzel Gläser) were presensitized with 10 µM 5-bromo-2'deoxyuridine (BrdU, Sigma-Aldrich) for 24 hr at 37°C. Damage was introduced with a 405 nm laser diode (3 mW) focused through a Plan-Apochromat 63x /1.4 oil objective to yield a spot size of 0.5-1 µm using a LSM710 NLO confocal microscope (Zeiss) and the following laser settings: 40% power, 50 iterations, scan speed 12.6 µsec/pixel.
Cell extracts and western blot
Total extracts were obtained by scraping cells in Laemmli buffer (50 mM Tris HCl pH 6.8, 1.6% SDS (Sodium Dodecyl Sulfate), 8% glycerol, 4% β-mercaptoethanol, 0.0025% bromophenol blue) followed by 5 min denaturation at 95°C. Cytosolic and nuclear extracts were obtained as previously described (Martini et al., 1998) . The chromatin fraction was prepared by addition of benzonase (Novagen) to the pellet after nuclear extraction.
For western blot analysis, extracts were run on 4%-20% Mini-PROTEAN TGX gels (Bio-Rad) in running buffer (200 mM glycine, 25 mM Tris, 0.1% SDS) and transferred onto nitrocellulose membranes (Amersham) with a Trans-Blot SD semidry transfer cell (Bio-Rad).
Total proteins were revealed by reversible protein stain (Pierce). Proteins of interest were probed using the appropriate primary and HRP (Horse Radish Peroxidase)-conjugated secondary antibodies (Jackson Immunoresearch), detected using Super-Signal West Pico or Femto chemi-luminescence substrates (Pierce). Alternatively, when fluorescence detection was used instead of chemi-luminescence, total proteins were revealed with REVERT total protein stain, secondary antibodies were conjugated to IRDye 680RD or 800CW and imaging was performed with Odyssey Fc-imager (LI-COR Biosciences) (see Table 4 for the list of antibodies 
Visualization of Replicative and Repair Synthesis
To visualize replicative synthesis, EdU (Ethynyl-deoxyUridine) was incorporated into cells during 15 min (10 µM final concentration) and revealed using the Click-iT EdU Alexa Fluor 594 (or 647) Imaging kit (Invitrogen) according to manufacturer's instructions. To visualize repair synthesis, EdU (10 µM final concentration) was incorporated into cells during 4 h immediately after local UVC irradiation and revealed using the same kit, before CPD labeling by immunofluorescence.
Nascent RNA labeling
Cells were incubated in DMEM supplemented with 0.5 mM EU (EthynylUridine) for 45 min, rinsed in cold medium and in PBS before fixation in 2% paraformaldehyde. EU incorporation was revealed with Click-iT RNA Imaging kits (Invitrogen) using Alexa Fluor 594 dye according to manufacturer's instructions.
Flow cytometry
Cells were fixed in ice-cold 70% ethanol before DNA staining with 50 µg/mL propidium iodide (Sigma-Aldrich) in PBS containing 0.05% Tween 20 and 0.5 mg/mL RNaseA ! 27! (USB/Affymetrix). DNA content was analyzed by flow cytometry using a FACS Calibur Flow Cytometer (BD Biosciences) and FlowJo Software (TreeStar).
Colony-Forming Assays
Cells were replated 48 h after siRNA transfection and exposed to global UVC irradiation (4, 8
and 12 J/m 2 ) the following day. Colonies were stained 10 days later with 0.5% crystal violet/20% ethanol and counted. Results were normalized to plating efficiencies.
Statistical analyses
Percentages of positively stained cells were obtained by scoring at least 100 cells in each See also, Figure S4 . See also, Figure S8 .
